908 Devices (MASS) Gains from Investment Securities (2020)
908 Devices (MASS) posted quarterly Gains from Investment Securities of $6.1 million for Q4 2020, up 3052.58% quarter-over-quarter from $194000.0 in Q3 2020.
908 Devices (MASS) Gains from Investment Securities (2020) Analysis & Trends
908 Devices (MASS) has reported Gains from Investment Securities for 1 consecutive years, with $6.1 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Gains from Investment Securities changed N/A year-over-year to $6.1 million; the TTM figure through Dec 2020 stood at $6.1 million (changed N/A YoY), while the FY2020 annual figure was $6.1 million, changed N/A from the prior year.
- Gains from Investment Securities rose to $6.1 million in Q4 2020 per MASS's latest filing, from $194000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $6.1 million in Q4 2020 and bottomed at -$191000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | 908 Devices | 398.03 Mn | 296.50 Mn | 8.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 6.12 Mn |
| Dec 31, 2020 | 6.12 Mn |
| Sep 30, 2020 | 194,000.00 |
| Sep 30, 2020 | 194,000.00 |
| Jun 30, 2020 | -191,000.00 |
| Jun 30, 2020 | -191,000.00 |
| Mar 31, 2020 | 23,000.00 |
| Mar 31, 2020 | 23,000.00 |